Home/ Crypto News/ Moderna (MRNA) Stock Soars 14% on Personalized Cancer Vaccine Success: Is It Time to Buy?
blockonomi Aug 25, 2026

Moderna (MRNA) Stock Soars 14% on Personalized Cancer Vaccine Success: Is It Time to Buy?

Stocks

Moderna (MRNA) stock jumps 14% as its personalized mRNA cancer vaccine meets Phase 3 trial goals. Analysts boost price targets, but is the rally sustainable?

The post Moderna (MRNA) Stock Soars 14% on Personalized Cancer Vaccine Success: Is It Time to Buy? appeared first on Blockonomi.

Source: Source: Blockonomi

Related News

Trending Category

200-day moving average 24/7 trading 4-Year Cycle AAP Stock AB 2409 AI AI Agents AI Data Centers AI IPO market AI Infrastructure AI Stocks AI automation AI backlash AI capital rotation AI spending AI trading AMD Stock AML AML compliance AMM Liquidity Pools

Latest News

Exchange Here